Kanazawa, T.; Kurano, T.; Ibaraki, H.; Takashima, Y.; Suzuki, T.; Seta, Y.
Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478. Pharmaceutics 2019, 11, 689.
https://doi.org/10.3390/pharmaceutics11120689
AMA Style
Kanazawa T, Kurano T, Ibaraki H, Takashima Y, Suzuki T, Seta Y.
Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478. Pharmaceutics. 2019; 11(12):689.
https://doi.org/10.3390/pharmaceutics11120689
Chicago/Turabian Style
Kanazawa, Takanori, Takumi Kurano, Hisako Ibaraki, Yuuki Takashima, Toyofumi Suzuki, and Yasuo Seta.
2019. "Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478" Pharmaceutics 11, no. 12: 689.
https://doi.org/10.3390/pharmaceutics11120689
APA Style
Kanazawa, T., Kurano, T., Ibaraki, H., Takashima, Y., Suzuki, T., & Seta, Y.
(2019). Correction: Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles. Pharmaceutics, 2019, 11(9), 478. Pharmaceutics, 11(12), 689.
https://doi.org/10.3390/pharmaceutics11120689
